)
Visual
test
Cyxone
Cyxone (CYXO) investor relations material
Cyxone has been delisted
Cyxone Q2 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2024 earnings summary29 Aug, 2024
Executive summary
Focus on advancing rabeximod (Phase 2 for RA) and T20K (early clinical for MS), aiming for cost-effective development and key milestones to attract partners.
New CEO Kjell Stenberg and interim CFO Henrik Hang appointed; Maarten Kraan joined as board member.
Rights issue completed in August, raising approximately SEK 6.4 million to fund prioritized studies.
Financial highlights
Net sales remained at SEK 0.0 million for Q2 2024, unchanged year-over-year.
Operating loss for Q2 2024 was SEK -4.7 million, compared to SEK -4.9 million in Q2 2023.
Cash and cash equivalents at period end were SEK 6.3 million, down from SEK 15.1 million a year earlier.
Equity at period end was SEK 29.6 million, compared to SEK 36.8 million in Q2 2023.
Cash flow from operations for Q2 2024 was SEK -4.8 million, improved from SEK -5.5 million in Q2 2023.
Outlook and guidance
Proceeds from the rights issue will be used for prioritized studies in rabeximod and T20K.
Updated development plans and operational efficiency measures are underway.
Long-term goal is to secure partnerships or buyers for projects after Phase 2 studies.
Current cash runway after rights issue?
What specific milestones attract partners?
What further cost reductions are planned?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- WAFD
All proposals passed with strong support; focus remains on innovation, competition, and shareholder value. - AVY
FY25 adjusted EPS up 1% to $9.53, $8.9B sales, and $861M returned to shareholders. - LLY
Q4 2025 revenue rose 43% to $19.3B; 2026 guidance set at $80–$83B revenue. - TKR
Q4 2025 outperformed; 2026 targets higher sales, margins, and EPS amid ongoing transformation. - POWL
Record backlog, strong orders, and margin expansion drive robust outlook for 2026. - AFG
Record 2025 results, strong ROE, and $707M+ capital returned, with robust 2026 outlook. - RNR
Net income hit $2.65B and book value rose over 26%, driven by strong property and investments. - OCSL
Net investment income covered the dividend as NAV fell and new investments remained strong. - BTBT
$888M in ETH and AI assets held, with shares trading at a 31% discount to mNAV. - PRU
Earnings rose, capital returns were strong, but Japan's sales pause will cut 2026 earnings.
Cyxone
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Cyxone is a Swedish biotechnology company focused on developing innovative treatments for autoimmune and immune-related diseases. The company's research and development efforts center on creating therapies that modulate the immune system to treat conditions such as rheumatoid arthritis and multiple sclerosis. The company is headquartered in Malmö, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage